Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

How MDliaison aims to help life science organizations find experienced sales staff

By Brian Buntz | November 8, 2022

MDliaisonIn 2021, Cherese Paloni founded MDliaison to connect healthcare sales reps with health care companies. After working as a sales rep, Paloni determined to address the high turnover rate in the life sciences industry.

After determining that the high turnover in the non-health-care-provider community is a symptom of an antiquated onboarding process, Paloni decided to create a network for healthcare sales contractors with established physician relationships.

MDliaison helps life sciences organizations find pre-vetted professionals. The company has created an open marketplace that facilitates the onboarding of qualified candidates. MDliaison ensures that professionals in the network have completed rigorous interviewing, testing and background and qualification checks. Most of the professionals in MDliaison’s network have substantial experience, with 65% having worked for the top five pharmaceutical and biotech companies. The company also serves the needs of health care providers, hospital networks and medical device organizations.

MDliaison boasts that it can reduce a candidate engagement cycle that traditionally took multiple weeks down to a matter of days while lowering operational costs. According to the startup, the increasing sophistication of screening candidates can reduce staff churn.

In the following interview, MDliaison CEO Paloni shares what attracted her to working in the life sciences industry, which projects she finds most compelling and which leadership skills she values most. Paloni has worked in both clinical and medical-business settings, including in pharma settings.

How did you get into the medical industry?

Cherese Paloni

Cherese Paloni

Paloni: I first started in the medical industry on the clinical side, working with emergency psychiatric patients at Vanderbilt Medical Center. I had just graduated with a bachelor’s in psychology and was going into the medical field to help psych patients at that time.

Please describe your work experience with healthcare companies.

Paloni: After being on the clinical side working on the front lines in the ER, I realized how hard it was for psychiatric patients to receive care due to insurance constraints and lack of services. I also saw how medical people went above and beyond for patients and worked very hard, but their employers treated them poorly. I felt that if I wanted to make a difference in how the healthcare system worked for workers and patients, I needed to pivot to healthcare administration.

I went on to work in sales and strategy with various healthcare organizations such as health technology, hospital, physician practice and neurorehabilitation. All the companies I chose to work for had strong patient-focused missions where I still felt that I was making a difference with patients as I had at the beginning of my career, but on the business side.

What projects, past or present, have made you love what you do? What projects are you most looking forward to?

Paloni: I have always loved to connect people and build things. I loved past sales roles when I was taking over a new territory, or it was a new role, and I was able to build our business from nothing into a top territory. This, coupled with being able to help my customers find the facility or product for their patients even if it may not be the service or product I was selling.

When I worked for a neurorehabilitation company, there were only a few resources for brain injury and stroke patients. So I had taken it upon myself to compile a 50-page book on services and facilities for families, physicians and nurses in the Bay Area. That project made me love being in sales and connecting them to those resources to receive proper treatment and rehabilitation.
The projects I get most excited about are working with companies that have a life-changing service or product for a patient, and they are looking to hire the first person to help them get their product in the market. It is a great feeling knowing you made that connection happen.

Describe your biggest leadership challenge. How did you conquer or resolve it, or what was the outcome?

Paloni: I think the biggest challenge in leadership I have faced is running my own company. I am not the expert in every department within the organization, so I must rely on others to be the expert and trust that they will make decisions and do the best job for the organization. Learning trust and being honest about performance are two ways I have conquered this challenge, which has helped move our organization forward.

Talk about your leadership skills. What is the most important lesson you have learned that has guided your career?

Paloni: The most important lesson I have learned in my career is to treat everyone with respect and kindness because you never know when they may circle back into your life again, and you may need them. This helped me when I led teams in my sales career and built relationships with external partners. It has become even more guiding when I started this company, and I needed help from people I have met in my career who could provide me with advice and support.

As I lead my organization, it is still my mantra because we cannot retain or keep top talent and keep our customers by not being respectful and kind.

What more can be done to promote greater participation of young women in the pharma industry today?

Paloni: There are great opportunities for career advancement within the pharma industry, especially in sales. However, pharma companies and other organizations need to help support new reps with mentorship to help guide their career. In addition, there needs to be more transparency in educating about the role of sales in pharma. Most people think it’s a cushy job with a high salary, but that is not true. The position requires a lot of pharmacology training on top of building relationships and educating physicians. Changing that misconception by focusing on the positive impact these roles make on patient care is important.


Filed Under: Drug Discovery and Development, Women in Pharma and Biotech
Tagged With: MDliaison
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

Collage of close-up male and female eyes isolated on colored neon backgorund. Multicolored stripes. Concept of equality, unification of all nations, ages and interests. Diversity and human rights
How a ‘rising tide’ of inclusivity is transforming clinical trials
Mary Marcus appointed CEO of NewAge Industries
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
Data analytics tools help doctors analyze trends in patient outcomes and population health.
External comparator studies: What researchers need to know to minimize bias
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE